Axillary nodal metastasis in ovarian cancer: a report of three cases and review of literature

Mohammad Zuhdy1, Reham Alghandour2, Gena Abdelazeem3, Gehad A. Saleh4, Mahmoud Saleh1, Mohamed Hamdy1, Omar Hamdy1
1Surgical Oncology Unit, Oncology Center, Mansoura University, Mansoura, 35516, Egypt
2Medical Oncology Unit, Oncology Center, Mansoura University, Mansoura, Egypt
3Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
4Radiology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Tóm tắt

Abstract Background Ovarian cancer represents a major global health burden that is rarely associated with distant metastasis. Axillary lymph node metastasis from ovarian cancer is rare and is reported only in few case reports in literature. Case presentation We report three cases of ovarian carcinoma associated with axillary lymph node metastasis as well as a brief literature review. The pathologic subtype in one case was malignant mixed Mullerian tumor, while the other two cases were high-grade serous ovarian carcinoma. Axillary nodal metastasis was reported as a synchronous event in one case, while it was reported as recurrence events in the other two cases. Conclusion Physicians should be aware of this uncommon mode of metastasis in ovarian cancer cases. Multi-disciplinary discussion is crucial in the management of these cases to offer them the best suitable treatment.

Từ khóa


Tài liệu tham khảo

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.

Goyal H, Mattoo VK, Singla U. Isolated axillary lymph node metastasis from serous ovarian cancer. Case Rep Oncol Med. 2012;2012:307567.

Aydin Ç, Ünalp HR, Baloğlu A, İnci AG, Yiğit S, Yavuzcan A. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature. Arch Gynecol Obstet. 2009;279(2):203–7.

Cormio G, Rossi C, Cazzolla A, Resta L, Loverro G, Greco P, et al. Distant metastases in ovarian carcinoma. Int J Gynecol Cancer. 2003;13(2):125–9.

Mason C, Yokubaitis K, Hamilton R, Oza U, Shah Z, Spigel J, et al. Unusual presentation of metastatic ovarian carcinoma as an enlarged intramammary lymph node. Proc (Baylor Univ Med Cent). 2015;28(3):386–8.

Prat J. Oncology FCoG. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1–5.

Euscher ED, Silva EG, Deavers MT, Elishaev E, Gershenson DM, Malpica A. Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy. Am J Surg Pathol. 2004;28(9):1217–23.

Kamura T, Jeon JD. Lymph node metastasis in a gynecologic malignancy. Yonsei Med J. 2002;43(6):783–91.

Skagias L, Ntinis A, Vasou O, Kondi-Pafiti A, Politi E. Ovarian carcinoma presenting with axillary lymph node metastasis: a case diagnosed by fine-needle aspiration and brief review of the literature. Diagn Cytopathol. 2008;36(12):891–3.

Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Beecham JB, Bonfiglio TA. Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer. Hum Pathol. 1988;19(11):1273–9.

Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004;28(12):1646–51.

Ilhan B, Kılıç B, Karanlik H. Ovarian cancer presenting as an axillary mass: case series and literature review. Curr Res Transl Med. 2016;64(3):161–3.

Görkem SB, O’Connell AM. Abnormal axillary lymph nodes on negative mammograms: causes other than breast cancer. Diagn Interv Radiol. 2012;18(5):473–9.

Hockstein S, Keh P, Lurain JR, Fishman DA. Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy. Gynecol Oncol. 1997;65(3):543–7.

Orris B, Geisler J, Geisler H. Ovarian carcinoma metastatic to bilateral axillary lymph nodes. A case report. Eur J Gynaecol Oncol. 1999;20(3):189–90.

Ozmen V, Asoglu O, Karanlik H, Cabioglu N, Kecer M, Bakkaloglu H. Primary ovarian cancer presenting with axillary lymph node metastases: a report of two cases. Acta Chir Belg. 2007;107(1):75–7.

Legge F, Petrillo M, Adamo V, Pisconti S, Scambia G, Ferrandina G. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome. BMC Cancer. 2008;8(1):367.

Sughayer MA, Zakarneh L, Abu-Shakra R. Collision metastasis of breast and ovarian adenocarcinoma in axillary lymph nodes: a case report and review of the literature. Pathol Oncol Res. 2009;15(3):423–7.

Harrison B, Lerner DJ, Tenofsky PL, Reddy PS. Ovarian adenocarcinoma presenting as axillary lymphadenopathy. Kans J Med. 2010;3(2):35–7.

Demir L, Erten C, Yigit SC, Can A, Dirican A, Bayoglu V, et al. Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature. Contemp Oncol. 2012;16(2):108.

Choi JI, Kim SJ, Park SH, Kim HS. Solitary axillary lymph node metastasis without breast involvement from ovarian cancer: case report and brief literature review. J Korean Soc Radiol. 2014;71(5):249–53.

Patel TS, Shah C, Shah MC, Shah MJ. Axillary node metastasis from primary ovarian carcinoma. J Cytol. 2014;31(4):202–4.

Sibio S, Sammartino P, Accarpio F, dei Malatesta Framarino M, Biacchi D, Sollazzo B, et al. Axillary lymph node metastasis as first presentation of peritoneal carcinomatosis from serous papillary ovarian cancer: case report and review of the literature. Eur J Gynaecol Oncol. 2014;35(2):170–3.

Eitan R, Tsoref D, Sabah G, Salman L. Axillary lymph node metastasis in ovarian carcinoma: two case reports and review of literature. Gynecol Oncol Rep. 2017;22:94–6.

Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962.

Al-Hussaini M, Stockman A, Foster H, McCluggage W. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology. 2004;44(2):109–15.

Hynninen J, Auranen A, Carpén O, Dean K, Seppänen M, Kemppainen J, et al. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecol Oncol. 2012;126(1):64–8.